ALIVUS — Alivus Life Sciences Balance Sheet
0.000.00%
- IN₹110.89bn
- IN₹104.81bn
- IN₹23.87bn
- 97
- 22
- 27
- 46
Annual balance sheet for Alivus Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,156 | 5,122 | 2,838 | 3,014 | 5,487 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 7,268 | 7,152 | 9,183 | 9,320 | 11,017 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13,990 | 17,646 | 18,503 | 19,160 | 23,352 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,790 | 6,763 | 8,242 | 8,962 | 10,369 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 19,971 | 24,710 | 27,021 | 28,504 | 34,115 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12,214 | 3,840 | 4,965 | 4,388 | 4,702 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 12,443 | 4,167 | 5,639 | 5,181 | 5,941 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 7,527 | 20,543 | 21,382 | 23,323 | 28,174 |
| Total Liabilities & Shareholders' Equity | 19,971 | 24,710 | 27,021 | 28,504 | 34,115 |
| Total Common Shares Outstanding |